SAN FRANCISCO — A possible $66 billion takeover of health insurer Aetna by CVS Health could lower costs to both companies, leading to the hope that at least some savings might be passed through to patients — or it could be an sign that for a long-standing player in the medicine game, “the jig is up.”
On Thursday, the Wall Street Journal, citing unnamed people who said they are familiar with situation, reported CVS Healthcare was in talks to acquire Aetna for more than $200 per share. Representatives of both companies declined to comment on the report.
While at first glance, a bid by CVS, with its 9,000 national pharmacies, for Aetna might seem like the mouse swallowing the cat, it’s actually the opposite. The market capitalization of CVS is currently about three times that of Aetna, approximately $180 billion versus $60 billion. Continue Reading
Related short Video: Watch Now
Related Story from CNBC.com: Wall Street just uncovered some clues on Amazon’s medical ambitions